Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease

Drug Discov Today. 2024 Aug;29(8):104062. doi: 10.1016/j.drudis.2024.104062. Epub 2024 Jun 11.

Abstract

Neurodegenerative diseases are challenging to cure. To date, no cure has been found for Alzheimer's disease or Parkinson's disease, and current treatments are able only to slow the progression of the diseases and manage their symptoms. After an introduction to the complex biology of these diseases, we discuss the beneficial effect of selenium-containing agents, which show neuroprotective effects in vitro or in vivo. Indeed, selenium is an essential trace element that is being incorporated into innovative organoselenium compounds, which can improve outcomes in rodent or even primate models with neurological deficits. Herein, we critically discuss recent findings in the field of selenium-based applications in neurological disorders.

Keywords: Alzheimer’s disease; Parkinson’s disease; neuroprotection; oxidative stress; selenium.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Animals
  • Humans
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Organoselenium Compounds / pharmacology
  • Organoselenium Compounds / therapeutic use
  • Parkinson Disease* / drug therapy
  • Selenium / pharmacology
  • Selenium / therapeutic use
  • Selenium Compounds / pharmacology
  • Selenium Compounds / therapeutic use

Substances

  • Neuroprotective Agents
  • Organoselenium Compounds
  • Selenium
  • Selenium Compounds